Doxecitine and doxribtimine (MT1621)
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Thymidine Kinase 2 (TK2) deficiency | An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency | Phase 2 |
TK0102
Ongoing |
NCT03845712 2018-004277-27 2023-510427-29-00 |